Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.73
-0.1-1.28%
At close: Jun 15, 5:00 PM EST
$7.70
-0.03-0.39%
After Hours: 7:58 PM EST
SELLAS Life Sciences Group Inc Analyst Ratings
SLSNASDAQ
SELLAS Life Sciences Gr Analyst Ratings and Price Targets | NASDAQ:SLS | Benzinga
SELLAS Life Sciences Group Inc has a consensus price target of $6.5 based on the ratings of 2 analysts. The high is $10 issued by Maxim Group on March 12, 2026. The low is $3 issued by Cantor Fitzgerald on November 22, 2023. The 3 most-recent analyst ratings were released by Maxim Group, Maxim Group, and Cantor Fitzgerald on March 12, 2026, July 16, 2025, and November 22, 2023, respectively. With an average price target of $6.67 between Maxim Group, Maxim Group, and Cantor Fitzgerald, there's an implied -13.42% downside for SELLAS Life Sciences Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for SELLAS Life Sciences Gr
Loading calendar...
FAQ
What is the target price for SELLAS Life Sciences Gr (SLS) stock?
The latest price target for SELLAS Life Sciences Gr (NASDAQ:SLS) was reported by Maxim Group on March 12, 2026. The analyst firm set a price target for $10.00 expecting SLS to rise to within 12 months (a possible 29.87% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?
The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ:SLS) was provided by Maxim Group, and SELLAS Life Sciences Gr maintained their buy rating.
When was the last upgrade for SELLAS Life Sciences Gr (SLS)?
There is no last upgrade for SELLAS Life Sciences Gr
When was the last downgrade for SELLAS Life Sciences Gr (SLS)?
There is no last downgrade for SELLAS Life Sciences Gr.
When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on March 12, 2026 so you should expect the next rating to be made available sometime around March 12, 2027.
Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a maintained with a price target of $7.00 to $10.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $7.70, which is within the analyst’s predicted range.
